Published • loading... • Updated
Corbus Pharmaceuticals Launches Phase 3 Cancer Trial, Teases More Obesity Drug Data
Summary by MarketBeat
1 Articles
1 Articles
Corbus Pharmaceuticals Launches Phase 3 Cancer Trial, Teases More Obesity Drug Data
Corbus Pharmaceuticals (NASDAQ:CRBP) has started a Phase 3 study of its cancer drug CRB-701 and expects an exploratory readout from a separate frontline combination study in the first quarter of next year, CEO Yuval Cohen said at the Guggenheim Healthcare Innovation Conference. Cohen also discussed
·Sioux Falls, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
